BioCorRx Q2 2026: Going Concern Warning, Revenue Halved, Cash Down to $21K
BICX is trading near its 52-week low of $0.152 (0.0% above the low) on elevated volume (3.7× avg).
Summary
BioCorRx's Q2 2026 10-Q shows a going concern warning, cash of only $21K, and revenue down 50.6% YoY. The company needs immediate capital to survive.
Key Events · Earnings and Guidance · BICX
-
Going Concern Warning
Cash of $21,237 and a working capital deficit of $8,231,326 raise substantial doubt about the company's ability to continue as a going concern for the next twelve months.
-
Revenue Decline
Q2 2026 revenue fell 50.6% YoY to $87,970, primarily due to lower Lucemyra distribution sales.
-
Material Weaknesses
Management disclosed material weaknesses in internal control over financial reporting, including insufficient GAAP experience and lack of segregation of duties.
-
Financial Restatement
The company revised Q1 2026 financials due to a revenue recognition error that overstated revenues by $135,471.
Analysis · BICX · Industrial Applications And Services
A critical liquidity crisis is laid bare in BioCorRx's Q2 2026 10-Q. Cash has dwindled to $21,237, and the company carries a working capital deficit of $8.2 million. Management explicitly states substantial doubt about its ability to continue as a going concern. Revenue fell 50.6% year-over-year to $87,970, driven by declining Lucemyra distribution sales. The filing also discloses material weaknesses in internal controls and revises Q1 2026 financials due to a revenue recognition error. Insiders provided $650,000 in new equity financing, but this is insufficient to fund operations for the next twelve months.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BICX was trading at $0.15 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4M. The 52-week trading range was $0.15 to $1.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.